BRPI1010516A2 - Métodos de tratamento de edema relacionados à isquemia-reperfusão - Google Patents

Métodos de tratamento de edema relacionados à isquemia-reperfusão

Info

Publication number: BRPI1010516A2
Authority: BR; Brazil
Prior art keywords: reperfusion; ischemia; treatment methods; related edema; edema treatment
Prior art date: 2009-04-09

Application number

BRPI1010516-6A

Other languages

English (en)

Inventor

Thomas Michael Egan

Original Assignee

Univ North Carolina

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-09

Filing date

2010-04-09

Publication date

2015-08-25

2010-04-09 Application filed by Univ North Carolina filed Critical Univ North Carolina

2015-08-25 Publication of BRPI1010516A2 publication Critical patent/BRPI1010516A2/pt

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Dentistry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Environmental Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)

BRPI1010516-6A 2009-04-09 2010-04-09 Métodos de tratamento de edema relacionados à isquemia-reperfusão BRPI1010516A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16808909P	2009-04-09	2009-04-09
PCT/US2010/030556 WO2010118334A1 (en)	2009-04-09	2010-04-09	Methods of treating edema related to ischemia-reperfusion

Publications (1)

Publication Number	Publication Date
BRPI1010516A2 true BRPI1010516A2 (pt)	2015-08-25

Family

ID=42936599

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1010516-6A BRPI1010516A2 (pt)	2009-04-09	2010-04-09	Métodos de tratamento de edema relacionados à isquemia-reperfusão

Country Status (14)

Country	Link
US (1)	US20120064044A1 (pt)
EP (1)	EP2416651A4 (pt)
JP (1)	JP2012523432A (pt)
KR (1)	KR20120005025A (pt)
CN (1)	CN102458113A (pt)
AU (1)	AU2010233151A1 (pt)
BR (1)	BRPI1010516A2 (pt)
CA (1)	CA2757998A1 (pt)
EA (1)	EA201101349A1 (pt)
IL (1)	IL215604A0 (pt)
MX (1)	MX2011010616A (pt)
SG (1)	SG175133A1 (pt)
WO (1)	WO2010118334A1 (pt)
ZA (1)	ZA201107815B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA201001450A1 (ru) *	2008-04-09	2011-08-30	Зе Юнивёсэти Оф Ноф Кэрэлайн Эт Чэпл Хил	Способы регулирования реаранжировки актинового цитоскелета и формирования межклеточных промежутков
JP6000287B2 (ja) *	2011-03-03	2016-09-28	クォークファーマシューティカルズインコーポレーティッドＱｕａｒｋＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	肺疾患および損傷を治療するための組成物および方法
US10531655B2 (en)	2011-12-02	2020-01-14	The Regents Of The University Of California	Reperfusion protection solution and uses thereof
WO2018165656A1 (en)	2017-03-10	2018-09-13	The University Of North Carolina At Chapel Hill	Short-acting heparin-based anticoagulant compounds and methods
US11993627B2 (en)	2017-07-03	2024-05-28	The University Of North Carolina At Chapel Hill	Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides
CN111601603A (zh)	2017-11-03	2020-08-28	北卡罗来纳大学查珀尔希尔分校	具有抗炎活性的硫酸化寡糖
MX2020008417A (es)	2018-02-12	2020-11-11	Inimmune Corp	Ligandos de receptores de tipo toll.
EP3810152A4 (en)	2018-06-20	2022-04-27	The University of North Carolina at Chapel Hill	Cell protective methods and compositions
JP2023501568A (ja) *	2019-11-13	2023-01-18	ザユニバーシティオブノースカロライナアットチャペルヒル	肝虚血再灌流障害におけるヘパラン硫酸（ｈｓ）オリゴ糖の効果

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05139992A (ja) *	1991-11-13	1993-06-08	Ajinomoto Co Inc	ヒトａｄｆを含有する臓器保護剤
US6113918A (en) *	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US7960522B2 (en) *	2003-01-06	2011-06-14	Corixa Corporation	Certain aminoalkyl glucosaminide phosphate compounds and their use
WO2004085396A1 (ja) *	2003-03-26	2004-10-07	Mitsubishi Pharma Corporation	虚血再灌流障害の予防または治療剤、臓器保存剤およびスクリーニング方法
US20060211752A1 (en) *	2004-03-16	2006-09-21	Kohn Leonard D	Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7928132B2 (en) *	2004-08-06	2011-04-19	Ohio University	Methods for the amelioration of episodes of acute or chronic ulcerative colitis
CA2693237C (en) *	2007-08-03	2016-11-01	Opsona Therapeutics Limited	Anti-toll-like receptor 2 antibodies for use in the treatment of cardiac inflammatory conditions
EA201001450A1 (ru) *	2008-04-09	2011-08-30	Зе Юнивёсэти Оф Ноф Кэрэлайн Эт Чэпл Хил	Способы регулирования реаранжировки актинового цитоскелета и формирования межклеточных промежутков

2010
- 2010-04-09 AU AU2010233151A patent/AU2010233151A1/en not_active Abandoned
- 2010-04-09 CA CA2757998A patent/CA2757998A1/en not_active Abandoned
- 2010-04-09 SG SG2011073475A patent/SG175133A1/en unknown
- 2010-04-09 US US13/263,435 patent/US20120064044A1/en not_active Abandoned
- 2010-04-09 BR BRPI1010516-6A patent/BRPI1010516A2/pt not_active IP Right Cessation
- 2010-04-09 KR KR1020117026569A patent/KR20120005025A/ko not_active Withdrawn
- 2010-04-09 EP EP10762505.5A patent/EP2416651A4/en not_active Withdrawn
- 2010-04-09 MX MX2011010616A patent/MX2011010616A/es not_active Application Discontinuation
- 2010-04-09 EA EA201101349A patent/EA201101349A1/ru unknown
- 2010-04-09 CN CN2010800259139A patent/CN102458113A/zh active Pending
- 2010-04-09 JP JP2012504890A patent/JP2012523432A/ja active Pending
- 2010-04-09 WO PCT/US2010/030556 patent/WO2010118334A1/en active Application Filing
2011
- 2011-10-06 IL IL215604A patent/IL215604A0/en unknown
- 2011-10-25 ZA ZA2011/07815A patent/ZA201107815B/en unknown

Also Published As

Publication number	Publication date
CA2757998A1 (en)	2010-10-14
JP2012523432A (ja)	2012-10-04
EP2416651A4 (en)	2014-03-26
ZA201107815B (en)	2013-04-24
US20120064044A1 (en)	2012-03-15
SG175133A1 (en)	2011-12-29
AU2010233151A1 (en)	2011-11-17
MX2011010616A (es)	2012-03-14
IL215604A0 (en)	2011-12-29
EA201101349A1 (ru)	2012-05-30
WO2010118334A1 (en)	2010-10-14
KR20120005025A (ko)	2012-01-13
CN102458113A (zh)	2012-05-16
EP2416651A1 (en)	2012-02-15

Publication	Publication Date	Title
BRPI0910854A2 (pt)	2015-10-06	métodos de tratamento
BR112012005594A2 (pt)	2015-09-08	tratamento de câncer
BRPI0910259A2 (pt)	2015-12-01	métodos de tratamento de inflamação
DK2330887T3 (da)	2013-05-21	Behandlingsindretning
EP2488689A4 (en)	2014-12-17	LAUNDRY TREATMENT APPARATUS
BRPI0914841A2 (pt)	2015-10-27	aparelho de massagem
BR112012023753A2 (pt)	2016-08-23	tratamento de resíduos orgânicos
ATE526024T1 (de)	2011-10-15	Fluvoxamin vermeidende pirfenidontheraphy
LT2405869T (lt)	2021-11-10	Nutukimo gydymas
EP2435825A4 (en)	2012-11-28	METHODS OF TREATING DISEASES
BR112013033974A2 (pt)	2017-02-14	terapia de combinação
BRPI1010516A2 (pt)	2015-08-25	Métodos de tratamento de edema relacionados à isquemia-reperfusão
DK2173831T3 (da)	2012-09-17	Brøndbehandling
BR112013022820A2 (pt)	2016-12-06	método de tratamento
EP2415408A4 (en)	2012-03-14	Treatment device
BRPI1007543A2 (pt)	2016-02-16	tratamento de psoríase
HRP20160577T1 (hr)	2016-07-29	Liječenje osteoartritisa
BR112012004071A2 (pt)	2016-03-08	tratamento de petróleo
BRPI1013903A2 (pt)	2016-07-19	tratamentos terapêuticos utilizando centaquina
DK2437839T3 (da)	2013-07-01	Lysbehandlingsindretning
BRPI0922216A2 (pt)	2015-12-29	tratamento para glomerulonefrite
EP2266520A4 (en)	2014-03-19	Massage machine
BR112012010525A2 (pt)	2015-09-29	novos processos
IT1403226B1 (it)	2013-10-17	Trattamento impermeabilizzante
FI9141U1 (fi)	2011-03-15	Apuväline

Legal Events

Date	Code	Title	Description
2015-12-08	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 4A E 5A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.